Navellier & Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,532
| Closed | -$418K | – | 328 |
|
|
2021
Q4 | $418K | Sell |
3,532
-36
| -1% | -$4.26K | 0.06% | 229 |
|
|
2021
Q3 | $479K | Sell |
3,568
-138
| -4% | -$18.5K | 0.07% | 201 |
|
|
2021
Q2 | $600K | Sell |
3,706
-30
| -0.8% | -$4.86K | 0.09% | 180 |
|
|
2021
Q1 | $300K | Hold |
3,736
| – | – | 0.05% | 235 |
|
|
2020
Q4 | $203K | Buy |
+3,736
| New | +$203K | 0.04% | 264 |
|